Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2012 | 12-2011 | |
| Sales | 0 | 0 | 0 | 15,318 | 13,938 |
| Cost of Goods | N/A | N/A | N/A | 6,321 | 5,771 |
| Gross Profit | N/A | N/A | N/A | 8,997 | 8,167 |
| Operating Expenses | 52,241 | 11,961 | 0 | 8,598 | 10,209 |
| Operating Income | -52,241 | -11,961 | N/A | 720 | -1,271 |
| Interest Expense | 166 | 51 | 0 | 0 | 0 |
| Other Income | -1,005 | 159 | 0 | 39 | 52 |
| Pre-tax Income | -53,412 | -11,853 | 0 | 759 | -1,220 |
| Income Tax | -1 | -1 | N/A | 14 | 0 |
| Net Income Continuous | -53,411 | -11,852 | N/A | 745 | -1,220 |
| Net Income | $-53,411 | $-11,852 | $N/A | $745 | $-1,220 |
| EPS Basic Total Ops | -166.93 | -40.14 | N/A | 0.07 | -0.12 |
| EPS Basic Continuous Ops | -166.93 | -40.13 | N/A | 0.07 | -0.12 |
| EPS Diluted Total Ops | -166.93 | -40.14 | N/A | 0.07 | -0.12 |
| EPS Diluted Continuous Ops | -166.93 | -40.13 | N/A | 0.07 | -0.12 |
| EBITDA(a) | $-51,990 | $-11,452 | $N/A | $1,976 | $203 |